Two-part safety, tolerability, pharmacodynamic and –kinetic study of inhaled AZD8871 in asthmatic and COPD subjects

Trial Identifier:	D6640C00001
Sponsor:	AstraZeneca
NCTID::	NCT02573155
Start Date:	October 2015
Primary Completion Date:	August 2016
Condition:	Asthma; Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Harrow, United Kingdom
United Kingdom	Manchester, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.